The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use

Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network

Barbara J. Stoll, Nellie I. Hansen, Edward F. Bell et al. · PEDIATRICS · 2010 · 2.7K citations · Full text

Public Health, Child Health, Pediatrics +17

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy

Stuart A. Scott, Katrin Sangkuhl, E E Gardner et al. · Clinical Pharmacology & Therapeutics · 2011 · 483 citations

Medicine, Cardiology, Pharmacology +17

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy

Timothy S. Tracy, Raman Venkataramanan, Douglas D. Glover et al. · American Journal of Obstetrics and Gynecology · 2005 · 442 citations

Medicine, Pharmacokinetics, Pharmacology +16

Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids

Kelan G. Tantisira, Stephen Lake, Eric S. Silverman et al. · Human Molecular Genetics · 2004 · 322 citations · Full text

Veterinary Medicine, Genetics, Pharmacology +17

Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice

Xuetao Ma, SB Naraharisetti, K M Krudys et al. · Clinical Pharmacology & Therapeutics · 2009 · 265 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17